Cosmetic label requirements are the mandatory informational elements, format rules, language provisions, and placement standards that each regulatory jurisdiction imposes on cosmetic products sold in its market.
Two audiences read the same surface: the consumer and the regulator.
A cosmetic label is a regulatory document that happens to look like marketing.
The EU, USA, and Great Britain each impose different mandatory requirements, and a label compliant in one market is rarely compliant in another without modification.
After 30 years in the hair and beauty sector, most recently in private label cosmetics, label compliance is where founders most consistently underestimate complexity.
Everyone thinks a good designer can handle it. A good designer handles the aesthetics. The regulatory content must come from compliance, and the production feasibility must come from packaging and printing.
For the broader global compliance picture, the EU framework, the US FDA framework, and the UK post-Brexit framework, see those guides.
Disclaimer: I am not a lawyer or regulatory professional. This is practical industry perspective, not legal advice. Work with a qualified regulatory consultant in each market.
This guide compares mandatory elements across the three markets, symbols and PAO, language with printing constraints, the label as brand surface, and a pre-production checklist.
Every cosmetic market requires a specific set of mandatory information on the label.
The overlap is significant, but the differences are operationally decisive.
Nine core label elements span all three markets with variations in detail.
Product identity or name. The US under 21 CFR 701.11 specifies the identity statement on the Principal Display Panel (PDP). The EU is different: the closed list of mandatory particulars in Article 19(1) of Regulation (EC) No 1223/2009 contains no product name and no identity statement. What Article 19(1)(f) requires is the function of the product, unless it is clear from its presentation, and Great Britain inherits the same architecture under UKCR Article 19. A product name is a commercial necessity, not an EU labeling obligation.
Function or product category. Required when the function is not obvious from presentation (EU and UK Article 19). The US does not require an explicit function statement but the identity statement must convey the product category.
Net quantity of contents. Required across all three markets, with exemptions, placement and format variations. EU and UK: nominal content at the time of packaging, given by weight or by volume, with packaging containing less than five grams or five millilitres, free samples and single-application packs exempt. Where a pre-package is normally sold as a number of items and details of weight or volume are not significant, the number of items on the packaging takes its place, and that number itself can be left out where it is easy to see from the outside or the product is normally sold individually. US: net quantity in the lower 30 percent of the PDP.
Ingredient list. Required across all three markets but in different formats. EU and UK: the common ingredient name from the glossary the Commission compiles under Article 33, which takes account of INCI, and a term from a generally accepted nomenclature where no common name exists, preceded by the word "Ingredients," in descending order of weight at the time the ingredients are added, with ingredients in concentrations of less than 1 percent free to be listed in any order after those in concentrations of more than 1 percent. Colorants other than hair colorants may be listed in any order after the other ingredients, in CI nomenclature where applicable, and a decorative range sold in several shades may list all of its non-hair colorants together with "may contain" or "+/-". US: common or usual name which in practice means INCI, descending order of predominance, but no mandatory "Ingredients" header word.
Name and address of the Responsible Person or business. Required in all three markets. EU: Responsible Person name and EU address, with multiple addresses allowed provided the one where the PIF is made readily available is highlighted. The Regulation prescribes the result, that it must stand out, not the technique: bold, underline, capitals or a box all work. US: manufacturer, packer, or distributor name and place of business, which may be outside the US. Great Britain: UK Responsible Person name and UK address, not an EU address; in Northern Ireland the EU regime applies and an EU address is compliant.
Country of origin. Required for imported products in all three markets. EU and UK: the country of origin must be specified for imported products. The Regulation requires the information, not a fixed wording, and "Made in [country]" is simply the usual way to give it. US: country of origin marking under US Customs rules plus FTC rules for "Made in USA" claims.
Batch number or lot identifier. Required in EU and UK for traceability. Not required as a federal element in the US but universally applied by industry.
Minimum durability or Period After Opening (PAO). Required in EU and UK, except where durability after opening is not a relevant concept for a product with a minimum durability of more than 30 months. Not required in the US for pure cosmetics. Products that are also OTC drugs, such as sunscreens, anti-acne products and fluoride toothpaste, fall under the drug rule on expiration dating, which 21 CFR 211.137(h) does not enforce where the labeling bears no dosage limitations and stability data show at least three years.
Warnings and precautions. Required in all three markets where applicable. EU and UK: the particular precautions to be observed in use, and at least those listed in Annexes III to VI, so an entry for a restricted substance (III), a colorant (IV), a preservative (V) or a UV filter (VI) carries its own mandatory wording where the entry sets one and the condition that triggers it is met, plus any special precaution for products intended for professional use. US: warnings specified in 21 CFR 740 for specific product categories plus the MoCRA adverse event reporting contact, which products that are also OTC drugs do not carry (Section 613).
Two elements distinguish EU and UK compliance from US compliance.
Durability indication. For products stable more than 30 months, the Period After Opening symbol (an open jar followed by the period, in months and/or years, commonly written as a number and "M") is mandatory, except where durability after opening is not a relevant concept. For products stable 30 months or less, a date of minimum durability must appear, preceded either by the hourglass symbol from Annex VII point 3 or by the words "best used before the end of": the two are alternatives, and the symbol alone is never mandatory. The US has no parallel requirement for pure cosmetics.
Function declaration. EU Article 19 and UKCR Article 19 require the product function to be stated explicitly when it is not obvious from the product presentation. A "serum" whose presentation as a whole leaves the function unclear needs an explicit function statement. The US uses the identity statement to convey function without a separate explicit declaration.
Under the post-MoCRA framework, two elements are US-specific.
Adverse event reporting contact. Under MoCRA, the label must give one route through which the Responsible Person can receive adverse event reports: a domestic address, a domestic phone number, or electronic contact information such as a website. The three are alternatives, one is enough. Section 613 (21 U.S.C. 364i) exempts a cosmetic product or facility that is also subject to the requirements of chapter V of the FD&C Act, the drug chapter, from sections 605 to 611. The exemption follows the chapter, not the over-the-counter status, and it does not reach a facility that also makes cosmetic products outside chapter V.
MoCRA Responsible Person identification. Section 604 of the FD&C Act (21 U.S.C. 364(4)) defines the US Responsible Person as the manufacturer, packer or distributor whose name appears on the label under Section 609(a) of the Act or Section 4(a) of the Fair Packaging and Labeling Act. The FPLA is one of the two routes the definition points to, not the seat of the definition, and the concept differs from the EU and UK Responsible Person.
UK address for the Responsible Person. A Great Britain label must show a UK-based Responsible Person address. An EU address on a label sold in Great Britain does not meet the Great Britain requirement. Direct Brexit consequence and one of the most common oversights for brands moving products between markets.
| Element | EU | USA | Great Britain |
|---|---|---|---|
| Product name/identity | Not required (commercial necessity, not a labeling obligation) | Required on PDP | Same as EU |
| Function statement | Required if not obvious | Conveyed via identity | Required if not obvious |
| Net quantity | Required (except under 5 g or 5 ml, free samples, single-application packs) | Required on PDP | Required |
| Ingredient list | Common ingredient names from the EU glossary, in practice INCI, descending order of weight, "Ingredients" header | Common name, descending order of predominance | Same as EU |
| Responsible Person/business | EU RP required | Name and place of business, US or not | UK RP required |
| Country of origin | If imported | Under Customs rules | If imported |
| Batch number | Required | Not federal | Required |
| Durability date or PAO | Date if 30 months or less, PAO if more than 30 months and durability after opening is relevant | Not for pure cosmetics | Same as EU |
| Warnings | Annexes III to VI plus category | 21 CFR 740 categories | Annexes III to VI plus category |
| MoCRA adverse event contact | Not required | Required, except products that are also OTC drugs | Not required |
A small set of standardized symbols appears on cosmetic labels across markets.
Knowing what they mean avoids the common misapplications. Knowing where to put them avoids the design problem every founder eventually runs into.
The PAO symbol, shown in point 2 of Annex VII of EU Regulation 1223/2009 and inherited into UKCR, is an open jar icon followed by the period for which the product stays safe after opening. That period is set by Article 19(1)(c), which allows it in months and/or years; in practice it is almost always a number and the letter "M" for months.
Examples: "6M" means safe for six months after opening. "12M" twelve months. "24M" twenty-four months.
When it is required. For products with a minimum durability exceeding 30 months in the EU and UK. The PAO replaces the date of minimum durability for longer-lasting products because the clock is consumer-use time, not shelf-sit time.
When it is not used. For products with a minimum durability of 30 months or less (use the date of minimum durability instead), for single-use products, for aerosols where opening concepts do not apply, and typically not for perfumes with very high alcohol content and long stability.
How the PAO is determined. The safety assessor or Responsible Person determines the PAO based on stability testing, preservative efficacy testing, and the product format. It is not an arbitrary marketing choice.
For products with minimum durability of 30 months or less, the label must display "Best used before the end of [date]" or the equivalent hourglass symbol defined in Annex VII point 3, followed by the date, or by details of where the date appears on the packaging.
Date format. Month and year is sufficient (for example, "Best used before the end of 06/2027"). Ambiguous formats get flagged during inspection.
When both symbols appear on a label. At most one of the two is the mandatory indication for a given product: the PAO when durability exceeds 30 months, the date of minimum durability when it is 30 months or less, and neither of them where durability exceeds 30 months but the concept of durability after opening is not relevant. Neither Article 19 nor Annex VII prohibits the other one from also appearing, so a label that carries both is redundant rather than in breach as long as the two indications agree; under Article 20(1) a figurative sign must not imply a property the product does not have, which a PAO longer than the actual durability would do.
Annex VII point 1 defines the hand-in-book symbol that refers the reader to information carried on an enclosed or attached leaflet, label, tape, tag or card, where it is impossible for practical reasons to put the precautions of use (Article 19(1)(d)) or the ingredient list (Article 19(1)(g)) where the Regulation requires them. Article 19(2) requires the reference itself, unless impracticable, and accepts either form: abbreviated information or the symbol. Where that reference must sit is not the same for the two: "on the container or packaging for the information referred in point (d)" and "on packaging for the information referred in point (g)". So a precautions reference may be carried on the container, an ingredient reference may not. Article 19(2) accepts only those physical carriers: a website or a QR code does not discharge the obligation.
The flame pictogram comes from other law, not from the Cosmetics Regulation: Annex VII lists three symbols, the flame is not one of them, and Regulation 1223/2009 never mentions flammability at all. On a cosmetic aerosol classified as flammable or extremely flammable the flame is mandatory, because the Aerosol Dispensers Directive 75/324/EEC as amended by Directive 2013/10/EU reprints the CLP labeling elements onto the dispenser, while a non-flammable aerosol carries the pressure warnings without it. On a non-pressurised flammable liquid such as an alcohol-based perfume, no EU act imposes it on the consumer label, because Article 1(5)(c) of CLP Regulation 1272/2008 keeps finished cosmetics intended for the final user outside CLP labeling. Many brands print it there anyway, and where it appears it belongs with the legible marks rather than in a decorative corner. The Green Dot is a private license mark, not a legal requirement: the EU Cosmetics Regulation does not mandate it and neither does national packaging waste law in France, Italy or Germany. Those laws ask for something else in each country: the Triman and Info-tri marking in France, the material coding of Decision 97/129/EC plus sorting information in Italy, and participation in a dual system in Germany, which carries no symbol. The E-mark before net quantity on EU labels indicates compliance with the e-measure packaging directive, optional but commonly used. Claims about recycled materials or compostable packaging are substantiation-sensitive and must be supported by evidence.
There is an uncomfortable part to all this.
Most of the mandatory visual elements are not beautiful.
The flammability flame on flammable aerosols, the waste-sorting tables required in several EU countries, the dense block of warning text for specific product categories, the allergen disclosure statements, the INCI list in its necessary length, the open-jar PAO icon with its industrial feel, and the small-print Responsible Person address. They exist to protect consumers and enable enforcement, not to make a cosmetic product look better.
The practical design strategy is to concentrate the mandatory content on the back or side panels of the packaging wherever regulation allows, and to keep the front panel dedicated to the brand identity, the product name, the function headline, and the minimum required identity elements.
This is legitimate label design, and it respects both the regulatory obligation and the commercial role of the product’s primary display panel. EU regulation does not require every element on the front. US FPLA specifies the PDP requirements (identity, net quantity) and allows other required information to sit on the information panel. UKCR follows the same architecture.
The mistake I see often is founders who try to make the warning text look nice on the front of the product, or who push symbols into decorative corners where they become illegible. Both are variations of the same error. You win by putting the flame symbol somewhere legitimate and legible, behind the brand’s visual hierarchy, not by making it elegant.
If you find yourself trying to hide mandatory elements or make them disappear, you are designing around compliance instead of with it.
The cleaner approach is to accept that the information panel does its job and make the principal display panel do yours.
Language and printing technique are where multi-market label design collides with production reality.
Both determine whether your compliant label can actually be produced, changed, or recovered when something goes wrong.
Under EU Regulation 1223/2009 Article 19(5), the national language rule covers the nominal content, the durability information, the precautions of use and the function of the product, which are points (b), (c), (d) and (f) of Article 19(1), plus the information covered by Article 19(2), (3) and (4). The language of those items is determined by the law of the member state where the product is made available to the end user. Point (c) is wider than the date: the words "best used before the end of" that introduce it and any conditions stated to guarantee the durability sit inside the same language rule.
In practice, each EU country specifies its required language. France requires French, Germany requires German, Italy requires Italian, Spain requires Spanish. Multi-language labels are universally used for products distributed across the EU.
Ingredient names stay in their original form. Article 19(6) sets the naming rule: the list uses the common ingredient name set out in the glossary provided for in Article 33, and a term from a generally accepted nomenclature where no common ingredient name exists. That glossary takes account of internationally recognised nomenclatures including INCI, so the glossary name is usually the INCI name, and it is written the same way across all EU member states rather than translated. The term "Ingredients" that precedes the list sits under Article 19(1)(g), which Article 19(5) does not cover, so the Regulation does not require its translation. Several member states nonetheless expect the local term, so check the national provisions of each market before deciding.
Warnings and instructions translated. "Avoid contact with eyes" must appear in each relevant language. Function statements must be translated.
Responsible Person address does not need translation. The name, street, city, and country of the RP are shown as they appear in the RP’s country of establishment.
UK. Great Britain works the same way. Article 19(5) of the assimilated Regulation points to regulation 5(3) of the Cosmetic Products Enforcement Regulations 2013, which requires the nominal content, the date of minimum durability, the precautions of use and the function, plus the information under Article 19(2) to (4), in English. The ingredient list, the Responsible Person block and the batch number are not caught. Multi-language UK labels are not required.
US. Under 21 CFR 701.2(b), all mandatory label information must be in English, with narrow exceptions for US territories where a different language is predominant, such as Puerto Rico. The critical rule catches European brands: if the label includes any information in a foreign language, all the required FD&C Act information must also appear in that language. A predominantly-English label with a French tagline triggers a requirement that the full mandatory information be duplicated in French. Either remove the non-English text or fully duplicate the mandatory information.
There is a production dimension here that most founders underestimate until it hits them financially.
Cosmetic labels are produced through several different techniques, and each has different cost dynamics for changes and corrections.
Self-adhesive labels (paper or plastic, pre-printed, then applied). The most flexible technique. A short sampling run of an updated artwork can often be produced for limited cost. The underlying unit cost is higher than direct-on-container techniques, but the correction cost is low. Best for brands expecting formula or regulatory updates, brands with lower volumes, and brands where visual complexity (gradients, many colors, photographic elements) matters.
Screen printing (silkscreen) directly on the container. A beautiful technique especially on glass and some plastics, delivers strong color and a premium feel, widely used for perfumes and higher-end skincare. But each color requires its own screen matrix. Changing any element of the artwork, even a single character in a warning, requires producing new screens. The cost of one punctuation correction includes matrix preparation, machine calibration, and often a minimum production run. Very low tolerance for errors caught late.
Pad printing (tampography). Used for curved surfaces, small containers, and specific production contexts. Similar cost dynamics to screen printing: die preparation and machine setup carry forward, and changes require re-tooling. Less visually versatile than screen printing but appropriate for specific formats.
Offset or flexo litho printing on sleeves or shrink labels. Cost-effective at volume, reasonable color fidelity, but change-cost dynamics depend on plate replacement needs. Suitable for larger runs where artwork stability is expected.
Direct digital printing. Increasingly used for smaller runs and pilot projects. Lower per-unit cost than traditional pre-press methods for small quantities, though limits on color and material choices can apply.
The concrete implication: a brand launching with screen printing on glass discovers at PIF review that the PAO symbol needs to change from "12M" to "9M" based on updated stability data. Or an updated SCCS opinion on an ingredient requires a new warning on the label. Or a retailer requests a minor disclaimer adjustment.
With screen printing, the correction means new matrices, new setup, and a minimum new production run.
The total cost of that correction can reach several thousand EUR/USD per product, before counting the stock already in inventory that may need to be relabeled or written off. (All cost figures in this article are indicative estimates that vary by provider, region, and project scope.)
With self-adhesive labels, the same correction costs a new artwork approval cycle and a new label run.
That is significantly less expensive, and faster.
The single most common operational failure I see in label design is this: the founder approves the artwork on a flat PDF or a monitor, without ever seeing the label rendered on the actual packaging shape.
When the printed label arrives and gets applied to the container for the first time, several things become visible that were invisible in the flat design. How the label wraps on the curve. How colors appear against the container material. How typography reads at actual product scale. How the hierarchy works when the product is held in hand at arm’s length. Whether the ingredient list text is legible at the real print size. Whether the mandatory symbols end up in coherent positions or get split across a seam.
By the time these problems appear, the matrices are made.
If you are on screen printing, the cost of fixing anything is high.
The discipline that saves money and launches faster is to ask your graphic designer (or your manufacturer, or your contract packaging partner) for a visual render of the label applied to the actual packaging, as close as possible to the final appearance, before final approval. A render, not a flat PDF. Preferably a 3D visualization or a physical mock-up on the exact container that will go into production.
This step is often skipped because it adds two or three days to the timeline. Those two or three days are the cheapest insurance you will buy on the whole project.
I had a client last year who approved label artwork on a monitor, skipped the render request, and committed to screen printing on a curved glass bottle. When the first production batch arrived, the product name sat exactly at the point where the label curved, stretching the typography badly. The brand name, which was supposed to be the point of the whole design, looked cheap. Correcting meant new screens, new setup, a six-week delay, and a real budget hit. Two days of render work at the approval stage would have caught it.
Before you sign off on any label artwork for production, especially if the printing technique makes corrections expensive, get the render. It is worth insisting on.
A brand selling across the EU, US, and Great Britain faces a geometric challenge.
Option A: separate labels per market. The simplest regulatory approach. Three label SKUs per product (EU, US, Great Britain) each optimized for its market. Highest production cost but lowest compliance risk.
Option B: multi-language EU label covering multiple EU markets. Universal practice for EU distribution, typically 5-8 languages on a single label covering major EU markets. Does not work for US or Great Britain.
Option C: EU and Great Britain shared label. Possible in principle because Great Britain accepts English and some EU markets also accept English. In practice, the Great Britain requirement for a UK-based Responsible Person address typically forces a separate label for that market anyway.
Option D: global label attempt. Some brands design one label in multiple languages hoping to cover EU, US, and Great Britain simultaneously. This almost never works. US rules on foreign-language information, UK Responsible Person requirements, and EU member state language rules collide.
In practice, most brands use separate EU and US labels, with the Great Britain label essentially a variant of the EU English version with a UK Responsible Person address swap.
A compliant label is the starting point, not the finish line. The label is also the densest contact surface between your brand and the consumer, and in 2026 the first contact in most purchase paths.
On the shelf, the label is the first element the customer perceives, before the product is opened, before the formula is experienced, before any marketing content is read. On an e-commerce listing, the label image is what convinces the customer to add to cart or move on.
Product quality remains the foundation. A well-designed label on a poorly-formulated product fails on the second purchase. But if the customer never reaches the first purchase, the formula quality is irrelevant to them because they never experienced it.
For physical retail and for e-commerce, the visual first contact carries disproportionate weight. That is how consumer decision-making actually works at the point of selection. Other supporting elements (the product scent, the packaging quality overall, your website, your content, influencer coverage) reinforce or correct the first-contact impression, but they come after the label has already done its job or failed it.
A label diverges from every other brand touchpoint you control.
Your website, your e-commerce product page, your brochures, your catalogs, your social content: all of these give you room to argue, explain, support a claim with evidence, use images and video, and sustain the customer’s attention for minutes.
A label does not. When the customer holds the product in hand, or sees the thumbnail on Amazon, the attention span is seconds. The customer does not read a label the way they read your about-us page. They scan. They find the product function, maybe a headline claim, the scent or variant, and move on.
Every word on the front of the label has to earn its place. Every element contributes to the impression or competes for the limited attention you have. A label that tries to say everything ends up saying nothing. A label with two or three sharp elements focused on what you want the customer to take away outperforms a label packed with seven benefits written in small type.
The implication is counterintuitive for many founders. More information is often worse, not better, because the noise-to-signal ratio drops. The discipline is to pick what matters most and give it space, not to fit everything that could matter.
A label communicates the brand, which means it cannot communicate anything coherent if the brand foundations (positioning, target avatar, tone of voice, visual identity) have not been defined. A brand that jumps to product name and label design before establishing its foundations ends up with a label that looks like a label but does not carry any particular message. The sequence that works is the one built on the reverse engineering approach, where foundations come first and product, packaging, and labels follow as extensions of the defined brand inside the broader ecosystem approach to building a cosmetic brand.
Current design trends (Scandinavian minimalism, K-beauty clean aesthetics) have pushed cosmetic design toward white space and minimal elements. The principle is sound: clean labels communicate confidence and quality. But minimalism done wrong becomes bland or generic. Clean design needs intentional color choices, considered typography, and deliberate brand elements. It is not just "removing things until there is nothing."
Whatever elements you choose to include, include them for a reason. Vivid colors work when they are deliberate. Many colors work when they support a story. Even dense typography works, as long as every element in it has a role. The discipline is intentionality, not minimalism for its own sake.
When brand foundations meet implementation, the label stops being a decision you can take on its own. It interacts with the packaging shape, the closure system, the printing technique, and the production volumes.
A brand that develops a beautiful colorful multi-gradient graphic, then picks a square-based packaging because it looks structural, then discovers the chosen printing technique is screen printing (which handles gradients poorly), ends up with either a compromised visual or an expensive reformulation of the decision chain. Each choice constrains the next.
A brand that picks an elegant curved bottle, then discovers the label does not adhere well to the concave curve, has to either change the bottle, change the label material and adhesive, or accept a visible seam.
Or commit to a wrap-around full-coverage label and then find that the chosen bottle has a textured surface which disrupts the wrap: the same choice comes back again.
The pattern is consistent. Labels must be developed as a work-in-progress alongside packaging, printing, and closure decisions, not designed first and then fitted. The sequence that consistently works is to sketch the visual direction early, validate the packaging options in parallel, test the printing technique fit, then lock the final design once all the pieces fit together.
The final operational piece before a label goes to production is verification. A structured checklist prevents most post-print corrections.
The same small number of failures comes back again and again.
Using the EU Responsible Person address on products for the Great Britain market is still the single biggest post-Brexit error in 2026.
A PAO symbol where the date of minimum durability was required (a product with 24-month durability carries a PAO and no date) is a direct regulation breach even though the information communicated is approximately the same.
Date of minimum durability in wrong format ("Best before 06/24" rather than "Best used before the end of 06/2024") gets flagged during inspection.
Missing function statement on EU or UK labels for serums, ampoules, essences, or other non-obvious product formats.
Ingredient list order errors on EU and UK labels, where ingredients above 1 percent are not in strict descending order of weight at the time they are added. Only ingredients in concentrations of less than 1 percent can be in any order.
INCI name errors, using a common name ("coconut oil" instead of "Cocos Nucifera Oil") or a trade name.
Drug claims on US cosmetic labels like "treats acne" or "heals skin" that turn the product into an unapproved drug.
Missing MoCRA adverse event contact on US products that need one, often overlooked on labels designed before MoCRA implementation. Products that are also OTC drugs sit outside the requirement under Section 613.
"Cruelty-free" claims used ambiguously without standardized regulatory definition backing.
Font sizes too small for the applicable US minimum: 1/16 inch for the ingredient declaration (21 CFR 701.3(b)), dropping to 1/32 inch where the package has less than 12 square inches of surface available for labeling (21 CFR 701.3(p)), while the net quantity declaration scales with the principal display panel under 21 CFR 701.13(i), from 1/16 inch up to 5 square inches to 1/2 inch above 400. Or too small for the EU/UK standard, which is "indelible, easily legible and visible lettering" under Article 19(1).
This is a general checklist, not a final compliance list. It must be adapted to each specific project, product category, and target market. Always run the final label through your Responsible Person or regulatory consultant before committing to production.
Identity and function
Ingredient declaration
Responsible Person / business
Quantity and identification
Durability and PAO
Warnings and precautions
Language
Visual and production
Final verification
Building a personal checklist is one of the most practical habits I recommend to founders. It saves real money. Mine has evolved over 30 years of watching the same mistakes happen at the same stages. Adapt this to your own workflow, add the details specific to your market and product category, and use it every single time before committing to a print run. The correction you catch during checklist review costs a PDF revision. The correction you catch after production costs a full production run.
The checklist is a pre-filter. It catches the recurring errors and lets your Responsible Person or regulatory consultant focus on the genuinely edge-case judgments that require their expertise, and it does not replace that review.
Can I use one cosmetic label for the EU, USA, and Great Britain?
Almost always no; the three markets have enough differences in mandatory elements, Responsible Person requirements, and language rules that a single label usually cannot satisfy all three without compromise. Great Britain requires a UK-based Responsible Person address, not an EU one. The US requires a MoCRA adverse event reporting contact, except for products that are also OTC drugs (Section 613), and neither the EU nor the UK asks for one, while the EU and UK require a date of minimum durability or a PAO indication not required for pure cosmetics in the US. The US language rule (all mandatory information must appear in any language used on the label) creates specific problems for multi-language EU labels sold in the US. In practice, most brands use separate EU, US, and Great Britain labels, with some shared artwork between EU and Great Britain (swapping the Responsible Person address where possible). Plan for a minimum of 9 to 15 label SKUs for a three-to-five product line across three markets.
What is the PAO symbol and when is it required?
The Period After Opening symbol is an open jar icon with a number and "M" (for example, "12M" for twelve months) defined in Annex VII of EU Regulation 1223/2009 and inherited into UK law. It is required on cosmetic products sold in the EU or UK when the product’s minimum durability exceeds 30 months, except where durability after opening is not a relevant concept. For products stable 30 months or less, the date of minimum durability is used instead, preceded either by the hourglass symbol of Annex VII point 3 or by the words "best used before the end of". The PAO tells the consumer how long the product remains safe after first use, not how long it lasts in storage. The specific PAO period is determined by the safety assessor based on stability and preservative efficacy testing. The US does not require a PAO for pure cosmetic products, and products that are both cosmetics and OTC drugs (sunscreens, anti-acne treatments) fall under the drug rule on expiration dating, which 21 CFR 211.137(h) does not enforce where the labeling bears no dosage limitations and stability data show at least three years.
What printing technique should I choose for my cosmetic labels?
The answer depends on production volumes, budget for future corrections, visual complexity, and the packaging format. Self-adhesive labels (pre-printed, then applied) offer the most flexibility for corrections and updates, with higher unit cost but lower error cost. Screen printing directly on glass or plastic delivers a premium visual impression, works well for perfumes and higher-end skincare, but carries high correction costs because any change requires new matrices. Pad printing suits curved surfaces and small containers with similar correction-cost dynamics to screen printing, offset or flexo litho works for larger runs on sleeves or shrink labels, and direct digital printing is increasingly used for smaller runs and pilot projects. For brands expecting regulatory or formulation updates within 12-18 months of launch, self-adhesive or digital-compatible approaches reduce the cost of inevitable corrections; for brands committing to a fixed formula and label design for several years, traditional techniques with higher upfront setup become more economical per unit.
Why do I need a render of the label on the packaging before production?
Because flat PDFs do not show how the label will actually look on the product. When a label is applied to a curved, tapered, or irregularly-shaped container, typography stretches or compresses in ways that are invisible on a flat design. Colors appear differently against the container material than on screen, hierarchy that works on a flat page can collapse on a three-dimensional object, and text that is legible on a monitor can become unreadable at the final print size. A render of the label applied to the actual packaging (preferably a 3D visualization or a physical mock-up on the exact container) catches these problems before matrices are made. This step adds 2-3 days to the timeline and typically costs a few hundred euros from a graphic designer. Skipping it, especially when committing to screen printing or pad printing where corrections are expensive, is where founders most frequently incur avoidable losses.
What language must my cosmetic label be in for EU, US, and Great Britain markets?
Each market has different rules. EU: Article 19(5) covers the nominal content, the date of minimum durability, the precautions of use and the function, and the language of those items is set by the law of the member state where the product is made available to the end user (France requires French, Germany requires German, and so on), while INCI ingredient names stay in Latin-based INCI form. US: all mandatory information must be in English with narrow exceptions for Puerto Rico, and if the label includes any information in a foreign language, all required FD&C Act information must also appear in that language. UK: the same four particulars, plus the information under Article 19(2) to (4), must be in English under regulation 5(3) of the Cosmetic Products Enforcement Regulations 2013, and the ingredient list is not caught. Multi-language labels for EU distribution (5-8 languages) are universal, and a US-market label must carefully control non-English decorative text.
What is the Responsible Person address requirement on cosmetic labels?
Each market requires the label to show the name and address of a specific legal entity responsible for the product’s compliance, but the definition of that entity differs. EU: the Responsible Person must be established in the EU, and their name and an EU address must appear on the label (with the address where the Responsible Person makes the PIF readily available highlighted, by any means that makes it stand out, if multiple addresses are shown). Great Britain: the UK Responsible Person must be established in the UK, and their UK address must appear on the label, because an EU address does not satisfy the Great Britain requirement. US: under FPLA and FDA requirements, the name and place of business of the manufacturer, packer, or distributor must appear on the label, along with city, state, and ZIP code. Under MoCRA, this entity is the "Responsible Person" for US product listing and adverse event reporting purposes. A brand selling in all three markets needs three separate compliant labels (or at minimum three address variants).
What are the most common cosmetic label compliance mistakes?
Ten patterns appear consistently across cosmetic label compliance failures. Market-identity group: using an EU Responsible Person address on products for the Great Britain market, carrying a PAO instead of the date of minimum durability on products stable 30 months or less, using an ambiguous date format, and missing a function statement on EU or UK labels for non-obvious products like serums and ampoules. Ingredient-declaration group: listing ingredients in marketing-priority order instead of the required descending order, and using non-INCI ingredient names. US-specific group: drug-type claims on US cosmetic labels that turn the product into an unapproved drug, and missing the MoCRA adverse event contact on the US product labels that need it, products that are also OTC drugs being exempt under Section 613. Claims-and-legibility group: using the "cruelty-free" claim without regulatory definition backing, and font sizes too small to meet legibility requirements. All ten are preventable with a pre-production compliance review by a qualified regulatory consultant or the Responsible Person, combined with a render of the label on the actual packaging before production commits.
Keep reading
Complete independent guide to cosmetics import/export documentation in 2026. EU, USA, and Great Britain customs requirements, HS codes, certificates of free sale, IOSS changes, MoCRA obligations, and the operational traps that cost founders the most. From 30 years in the industry.
Complete independent guide to cosmetic brand trademark protection in 2026. EUIPO, USPTO, UKIPO, and the Madrid System compared, Nice classes 3 and 5 explained, costs and timelines. From 30 years in the industry. Not legal advice.
Complete independent guide to MoCRA in 2026: mandatory facility registration, product listing, adverse event reporting, safety substantiation, GMP delay, and what international brands actually need to do. From 30 years in the industry.
